Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. - Wikidata - wikimedia - TriplyDB

Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening.

Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening.

http://www.wikidata.org/entity/Q50147740

about

Grafting techniques for Peyronie's disease Oral therapy for Peyronie's disease, does it work?Psychological aspects of Peyronie's disease A review of the epidemiology and treatment of Peyronie's disease Role of collagenase clostridium histolyticum in Peyronie's disease Psychosexual Symptoms and Treatment of Peyronie's Disease Within a Collaborative Care Model Nonsurgical treatment options in Peyronie's Disease: 2016 update Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease?US Imaging in Peyronie's Disease Tunica albuginea allograft: a new model of LaPeyronie's disease with penile curvature and subtunical ossification.A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States Effect of SMAD7 gene overexpression on TGF-β1-induced profibrotic responses in fibroblasts derived from Peyronie's plaque.Activin Receptor-Like Kinase 5 Inhibitor Attenuates Fibrosis in Fibroblasts Derived from Peyronie's Plaque.A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease.The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience.Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease.PDE5 inhibitors beyond erectile dysfunction.Peyronie's disease: a critical appraisal of current diagnosis and treatment.Collagenase Clostridium histolyticum in the treatment of Peyronie's disease: patient selection and perspectives.Current status of the surgical management of Peyronie's disease.Rat as an animal model for Peyronie's disease research: a review of current methods and the peer-reviewed literature.Treatment of Peyronie's disease: 2012 update.Understanding the course of Peyronie's disease.PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.Peyronie's disease: A contemporary review of non-surgical treatment.A critical analysis of the surgical outcomes for the treatment of Peyronie's disease.Peyronie's disease: contemporary review of non-surgical treatment.Innovative surgical techniques for managing Peyronie's disease: a video presentation.Association of the modified frailty index with adverse outcomes after penile prosthesis implantation.Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain.Peyronie's Disease: Intralesional Therapy and Surgical Intervention.Structured Self-Rated Response to Iontophoresis with Verapamil and Dexamethasone in Peyronie's Disease.A pilot study of penile hemodynamics in men with penile curvatures.Survey of patient and partner satisfaction following collagenase Clostridium histolyticum treatment for Peyronie's disease.Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction.Repurposing Pentoxifylline for the Treatment of Fibrosis: An Overview.Defining predictors of response to intralesional verapamil injection therapy for Peyronie's disease.Use of a lyophilized bovine pericardium graft to repair tunical defect in patients with Peyronie's disease: experience in a clinical setting.Prevalence of Peyronie's Disease-Like Symptoms in Men Presenting With Dupuytren Contractures.Risk factors for emotional and relationship problems in Peyronie's disease.

P2860

Q26746129-481C47F3-8C66-4CC6-B666-8E075A799F6A Q26746139-6D7C8725-34BB-432D-90C2-8C4A39BA13D3 Q26746142-34BC7A62-194B-48E9-9D53-1593659F0E6C Q26747269-E0111E19-5BBC-47B8-A35E-0890B136B0D4 Q26778518-4E32E535-66E8-4048-B158-56C46CB8CB77 Q26826879-BE156DCB-7F0B-481D-8033-AFAEFCCE046C Q28075809-1C98BEB0-B9A4-4422-B5F8-0AADB758CE34 Q30458422-67AADBA2-932B-434E-8543-3295F52D09DF Q30459971-09488E72-2A5D-4902-8F5C-4910F8E3A7AC Q33922413-CF0DC43D-EC5B-469B-9CDE-637DFB341C80 Q35450218-1268E8F0-90D5-4B63-AB35-B65FA5339C94 Q35604418-C9E7DF8B-448E-4B01-809F-F1DBAF3E95FC Q35738222-9887130D-0786-4674-AC18-32F9FCDF7E6A Q36037023-13160E8F-4C37-4B81-966C-9F8DE7D3266B Q36116915-B3ADF874-929A-4C36-98B1-3BFF47460989 Q36395176-E4FBAAC6-8A0F-4F9E-A4B7-B8293558D46F Q36878017-7265E25F-E10B-47E5-A4D2-BDBA5B1CB23B Q37225332-8BAF9A71-8149-4417-9DE7-102A30B8B41D Q37682832-51133CF9-8341-4C4F-85E3-613D2C152288 Q37838258-1AD24179-B925-4FA0-A792-77C99FFF2F0E Q37903227-82C9BC54-BF02-4404-8F1E-A49D3ACB86B3 Q37912058-816DC9AC-0432-4F16-BD20-A057C5C0AF48 Q38122722-E9594C4D-F281-44EB-9F79-7B90CFFD2BBF Q38568077-E9C0ACD5-326F-44DC-8BCF-B42345016E5E Q38630427-9A27FF10-CECB-42D4-AB1F-606779CCA8CC Q38630431-6465825D-F494-4722-9812-F05199E3BF7E Q38713713-4ACDF854-4557-40A4-903A-7FAE67CEBA4B Q38713736-F701AE24-9C56-4A83-B470-3837C63BC908 Q38738466-EF0AAB06-CF08-43B4-9C30-F0A146F0D84D Q38815958-11D73F41-77B6-4D76-BA28-73BD1C94F24F Q38901773-56DC04E3-81D1-4415-AEF0-202D3F51D928 Q38908920-3DBA9B28-95AC-4D54-A974-7A69797DAFFB Q39026033-6BFAC308-C852-42FC-8744-55049BB4EC8A Q39130562-72121914-6EC1-42B7-BEAA-7F880C75CBF3 Q39143837-2BE399E3-5BC8-4C0A-B2BE-64F86F888ED7 Q39292948-17D77820-2571-4E81-B4D5-DC8AC8F8F031 Q39731742-D7DEF7A4-6575-4BB5-9841-9D9A49A4DFA3 Q40066719-A4A51045-CBCC-495F-A82E-986479335C2A Q40135422-6A7047A6-1895-4C56-BCC4-0C15919C254D Q40913285-01C8EABF-74AD-440B-A3AC-560086C4D7CF

P2860

Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening.

http://www.wikidata.org/entity/Q50147740

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Subjective and objective analy ...... for prostate cancer screening.

@en

Subjective and objective analy ...... for prostate cancer screening.

@nl

type

label

Subjective and objective analy ...... for prostate cancer screening.

@en

Subjective and objective analy ...... for prostate cancer screening.

@nl

prefLabel

Subjective and objective analy ...... for prostate cancer screening.

@en

Subjective and objective analy ...... for prostate cancer screening.

@nl

P1433

Q50147740-A0B46BFF-85D1-4915-9133-5B007F1B185A

P1476

Q50147740-833B740D-28C3-48B5-8C5D-9DB6038C01BA

P2093

Q50147740-0A1DBD21-7C54-4962-A8CF-D5B959D1B153

Q50147740-28E1BB38-DADB-41A4-B873-85576A9F9439

Q50147740-315C684C-56D9-46FA-80F6-09E8BC0047B0

Q50147740-773E59CD-416D-4C8E-9265-C96315DB1F30

Q50147740-A7D97A68-CE7B-45B7-92D4-AD28EBE99882

Q50147740-AA689B67-0050-48A4-8ECF-556F8410612D

Q50147740-AC8D94D3-D13C-4604-A617-F4E24A198924

Q50147740-AFD56266-90EF-4C05-8193-6420652BA39B

P304

Q50147740-7D4E2BC8-52D5-4C07-B95F-2A169DFD5CD8

P31

Q50147740-2240ED2B-3C8C-4E7A-A17D-FE49779249E0

P356

Q50147740-174B389E-15F6-46B0-AC6B-F165F1D8F136

P407

Q50147740-0718DA72-DF68-4EE3-8F49-CCB0D42AB03E

P433

Q50147740-405CFE99-7888-432A-8F7D-BF07F76AB260

P478

Q50147740-3C215B2A-0898-4348-AAD2-2A927D041145

P577

Q50147740-B234409A-C00A-42E1-BA17-AA67F2DE90D3

P698

Q50147740-00E378EE-6087-4F81-97F2-B1FA2E9E9EE9

P356

01.JU.0000127744.18878.F1

P1433

The Journal of Urology

P1476

Subjective and objective analy ...... for prostate cancer screening.

@en

P2093

Ayham Moty

http://www.w3.org/2001/XMLSchema#string

Edward D Kim

http://www.w3.org/2001/XMLSchema#string

John P Mulhall

http://www.w3.org/2001/XMLSchema#string

Rodney Davis

http://www.w3.org/2001/XMLSchema#string

Sam Ghaly

http://www.w3.org/2001/XMLSchema#string

Stephen A Boorjian

http://www.w3.org/2001/XMLSchema#string

Steven D Creech

http://www.w3.org/2001/XMLSchema#string

Wayne Hellstrom

http://www.w3.org/2001/XMLSchema#string

P304

2350-2353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.JU.0000127744.18878.F1

http://www.w3.org/2001/XMLSchema#string

P407

P433

6 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15126819

http://www.w3.org/2001/XMLSchema#string